Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
DocCheck AG, founded in 1990 and headquartered in Cologne, Germany, provides marketing, customer relationship management, and e-commerce services tailored for the European healthcare sector. The company operates the DocCheck portal, a platform facilitating information exchange among healthcare professionals, and offers services such as online advertising, market research, and communication strategy development for healthcare and business-to-business sectors. Additionally, DocCheck AG invests in healthcare startups through its venture capital arm, DocCheck Guano AG. The company's subsidiaries include antwerpes AG, which develops integrated communication concepts for the healthcare sector, and DocCheck Shop GmbH, a leading e-commerce platform for medical and practice supplies in Europe.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
DocCheck AGEli Lilly
Last price
€10.35$1,427.28
Currency
EUR
USD
€53M$1.3T
11.2646.65
€0.92$30.81
0.960.39
€1.00$6.69
9.66%0.48%
Sector
HealthHealth
Employees
41450,000
Ticker
€AJ91$LLY
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €AJ91 or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.